M Stahl, J A Schifferli; The renal risks of high-dose intravenous immunoglobulin treatment., Nephrology Dialysis Transplantation, Volume 13, Issue 9, 1 Septembe
No takes yet. Share an insight, caveat, or question.
Michael Ståhl (1998) studied this question.